Lodhra

<h3> Absolute Contraindications of Lodhra </h3> <h4>Pregnancy (Do not use during pregnancy)</h4> <ul> <li> 🤰 <li> Recommendation: Avoid taking Lodhra during pregnancy; do not use it to treat pregnant people without specialist supervision. <li> Reasoning: Preclinical data show Lodhra extracts stimulate gonadotropin release and cause ovarian/uterine tissue changes in immature animals - effects that could alter hormone balance or uterine activity in pregnancy. <li> Scientific_Study_Title: Effect of Symplocos racemosa Roxb. on gonadotropin release in immature female rats and ovarian histology. <li> Scientific_Study_Authors: R. T. (author list as indexed) - (Rao/et al. style from PubMed record). <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/15261983/ <li> Scientific_Study_Excerpt: <p>The published animal study reports that oral administration of aqueous Symplocos racemosa bark extract significantly increased serum FSH and LH in immature female rats and produced histopathological ovarian changes consistent with enhanced folliculogenesis and mature follicles. Treated animals showed increased ovarian weight and detached oocytes, findings the authors interpret as a hormonal stimulatory effect. Because the extract altered central or ovarian hormone signalling and produced structural ovarian changes in a developing model, the study authors and subsequent reviewers advise caution about use in pregnancy or in populations where reproductive hormones must be tightly controlled.</p> </ul> <h4>Concurrent use with MAO inhibitors or strong serotonergic antidepressants</h4> <ul> <li> ⚠️ <li> Recommendation: Do not combine Lodhra (or concentrated Lodhra extracts) with MAO inhibitors or without specialist advice if you take SSRIs/SNRIs/other serotonergic drugs. <li> Reasoning: Isolated constituents from Lodhra showed MAO-A inhibitory activity in docking and preclinical tests and produced antidepressant-like effects in animals; combining with MAO inhibitors or potent serotonergic medicines risks excessive monoamine elevation. <li> Scientific_Study_Title: Preparation, In Vivo and Molecular Docking Study of Nano-Emulsion Obtained From the Isolated Phytoconstituents of Symplocos racemosa for Mitigating Depression. <li> Scientific_Study_Authors: (authors as listed on PubMed entry). <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/40079725/ <li> Scientific_Study_Excerpt: <p>Authors isolated multiple phytoconstituents from S. racemosa bark and performed molecular docking against MAO-A, reporting significant binding affinities comparable to an MAO-A inhibitor reference. A chitosan-loaded nano-emulsion containing these constituents produced reduced immobility time in forced-swim tests and increased locomotor activity in mice, consistent with MAO-A inhibition and monoaminergic enhancement. The paper highlights potential antidepressant mechanisms and therefore flags interaction risk when combined with pharmaceutical MAO inhibitors or other drugs that raise serotonin/norepinephrine levels.</p> </ul> <h4>Prepubertal children / immature individuals (growing children)</h4> <ul> <li> 🧒 <li> Recommendation: Avoid giving Lodhra extracts to children or adolescents without specialist paediatric/ayurvedic supervision. <li> Reasoning: Animal data in immature rats show stimulation of FSH/LH and ovarian maturation; altering the hormonal axis during growth could have unintended developmental effects. <li> Scientific_Study_Title: Effect of Symplocos racemosa Roxb. on gonadotropin release in immature female rats and ovarian histology. <li> Scientific_Study_Authors: (as indexed on PubMed). <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/15261983/ <li> Scientific_Study_Excerpt: <p>In the reported in vivo immature rat model, administration of aqueous S. racemosa extract produced a statistically significant rise in serum FSH and LH and histological evidence of increased folliculogenesis and ovarian maturation. Because the study used a developmental animal model, the authors indicate that the herb has biologic activity on the hypothalamic-pituitary-gonadal axis in immature subjects; by analogy, such activity suggests caution when used in children or adolescents until human safety data are available.</p> </ul> <h4>Active hormone-sensitive cancers or during hormone therapy (use with extreme caution)</h4> <ul> <li> 🎗️ <li> Recommendation: If you have active breast, endometrial, or other hormone-sensitive cancer, or are on hormone replacement/anti-hormonal cancer therapy, consult your oncologist before using Lodhra. <li> Reasoning: Phytochemicals in Lodhra (phenolics, flavonoids, triterpenoids) have biological activity on reproductive tissues; while direct human clinical data are limited, preclinical signals and traditional use for uterine conditions justify caution. <li> Scientific_Study_Title: A comprehensive analysis on Symplocos racemosa Roxb.: Traditional uses, botany, phytochemistry and pharmacological activities. <li> Scientific_Study_Authors: (authors as per PubMed indexing). <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/26851499/ <li> Scientific_Study_Excerpt: <p>This review compiles multiple preclinical studies showing that S. racemosa bark contains phenolic glycosides, triterpenoids and flavonoids with activities including hepatoprotective, anti-inflammatory and reproductive/tissue effects. The authors state that several studies confirm ethnobotanical claims for uterine and ovarian-related uses and note bioactive constituents that could modulate reproductive tissues. Because of these biologic activities, the review recommends careful safety evaluation and cautions in conditions sensitive to hormonal modulation, pending robust clinical data.</p> </ul> <h3> Relative Contraindications of Lodhra </h3> <h4>Breastfeeding (insufficient human safety data)</h4> <ul> <li> 🤱 <li> Recommendation: Avoid regular systemic use while breastfeeding unless advised by a clinician; topical or short single-use preparations may be lower risk but consult a lactation specialist. <li> Reasoning: There are no robust human lactation studies; because Lodhra alters reproductive hormones in animals and contains absorbable phytochemicals, transfer into breastmilk and effects on infants cannot be excluded. <li> Scientific_Study_Title: Bioprospecting the antimicrobial, antibiofilm and antiproliferative activity of Symplocos racemosa Roxb. Bark phytoconstituents along with their biosafety evaluation and detection of antimicrobial components by GC-MS. <li> Scientific_Study_Authors: Henna Sood, Yashwant Kumar, Vipan Kumar Gupta, Daljit Singh Arora. <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/33203457/ <li> Scientific_Study_Excerpt: <p>The BMC Pharmacol Toxicol study evaluated antimicrobial fractions of S. racemosa and conducted in vitro biosafety tests plus acute oral toxicity in mice. While the acute toxicity assessment showed no gross adverse changes at tested doses, the authors explicitly note a lack of chronic exposure and reproductive-lactational safety data in humans. The study thereby supports that short-term use appears safe in acute models but that data are insufficient to declare safety during breastfeeding.</p> </ul> <h4>Gastrointestinal hypomotility / predisposition to constipation</h4> <ul> <li> 💩 <li> Recommendation: Use cautiously if you already have slow gut motility or constipation; monitor bowel habits and reduce dose if constipation worsens. <li> Reasoning: Lodhra demonstrates antidiarrhoeal and gut-tone reducing effects in isolated intestinal preparations and animal models; these same effects can worsen constipation if present. <li> Scientific_Study_Title: Antidiarrhoeal, Anti-inflammatory and analgesic activities of Symplocos racemosa Roxb. Bark. <li> Scientific_Study_Authors: (authors as indexed on PubMed). <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/26045374/ <li> Scientific_Study_Excerpt: <p>Experimental work on isolated rabbit intestine and rodent models showed that crude and fractionated bark extracts of S. racemosa decreased intestinal smooth muscle tone and produced antidiarrhoeal activity, alongside anti-inflammatory and analgesic effects in mice and rats. The authors document dose-dependent reductions in intestinal motility and conclude that intestinal tone modulation underlies the antidiarrhoeal action; clinically, that mechanism can predispose to constipation if used in persons with baseline slow motility.</p> </ul> <h4>Long-term / high-dose use without monitoring</h4> <ul> <li> ⏳ <li> Recommendation: Avoid prolonged high-dose use without periodic medical review and monitoring (liver tests, menstrual assessment) because human long-term safety data are limited. <li> Reasoning: Preclinical and acute safety studies are supportive but long-term human safety, effects on liver metabolism and chronic reproductive effects are not established. <li> Scientific_Study_Title: A comprehensive analysis on Symplocos racemosa Roxb.: Traditional uses, botany, phytochemistry and pharmacological activities. <li> Scientific_Study_Authors: (as per PubMed indexing). <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/26851499/ <li> Scientific_Study_Excerpt: <p>The review synthesizes multiple in vitro and in vivo preclinical studies demonstrating beneficial pharmacology for S. racemosa but emphasises gaps in systematic clinical safety and chronic exposure data. The authors recommend controlled clinical studies and biomarker development before broad chronic therapeutic use, and advise clinicians to monitor organ function and reproductive markers when plant extracts are used long term.</p> </ul>